Addition of a Dopamine Agonist, Cabergoline, to a Serotonin-Noradrenalin Reuptake Inhibitor, Milnacipran as a Therapeutic Option in the Treatment of Refractory Depression: Two Case Reports (Q44603348)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of a Dopamine Agonist, Cabergoline, to a Serotonin-Noradrenalin Reuptake Inhibitor, Milnacipran as a Therapeutic Option in the Treatment of Refractory Depression: Two Case Reports |
scientific article published on September 1, 2003 |
Statements
1 reference
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports (English)
1 reference
Addition of a Dopamine Agonist, Cabergoline, to a Serotonin-Noradrenalin Reuptake Inhibitor, Milnacipran as a Therapeutic Option in the Treatment of Refractory Depression: Two Case Reports (English)
Hisashi Higuchi
1 reference
Hitoshi Takahashi
1 reference
Keizo Yoshida
1 reference
Tetsuo Shimizu
1 reference
Takeshi Inoue
1 reference
Tsukasa Koyama
1 reference
1 September 2003
1 reference
1 reference
26
1 reference
5
1 reference
230-232
1 reference
Identifiers
1 reference
1 reference